A Surge of Biologics for Severe Asthma - Managed Healthcare Executive


6/21/2022 12:00:00 AM3 years 8 months ago
by Rosanna Sutherby, Pharm.D.

Six biologics on the market and more are in the pipeline. Biologics target the inflammatory cytokines involved in the pathogenesis of asthma.

Asthma is a chronic respiratory disease that causes narrowing and inflammation of the airways that compromises breathing and, in some cases, can be fatal. Symptoms include coughing, wheezing, shortne… [+7603 chars]

full article...